Skip to main content
Log in

The State of Albumin Thiol Groups in Patients with the First Episode of Schizophrenia

  • Clinical Neurochemistry
  • Published:
Neurochemical Journal Aims and scope Submit manuscript

Abstract

In this paper, the state of the body’s antioxidant defense was studied using the state of thiol groups in the albumin in patients with their first episode of schizophrenia (FES). We examined 21 patients with the first psychotic attack of schizophrenia; the average severity of the disorders was 75 ± 2 points on the PANSS scale. All patients were examined prior to initiation of the drug therapy. The control group consisted of ten healthy volunteers. The concentration and reactivity of the albumin SH groups was determined in the reaction with dithionitrobenzoic acid. As a result of the study, we found a 24% decrease in the average reactivity of albumin SH groups in the FES group compared with the control group (p = 0.02). Using two parameters, that is, the concentration and reactivity of albumin thiols, it was possible to separate the patient group and the control group, with the probability of a relationship of the patient to the respective group of 86%. Thus, patients with the first episode of schizophrenia before the start of treatment are characterized by significant disturbances in the concentration and reactivity of the albumin SH-groups involved in redox processes in the body.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Similar content being viewed by others

References

  1. Gurovich, I.Ya. and Shmukler, A.B., Pervyi psikhoticheskii epizod (problemy i psikhiatricheskaya pomoshch’) (First Psychotic Episode (Problems and Psychiatric Help)), Moscow: Medpraktika-M, 2010.

    Google Scholar 

  2. Ohrmann, P., Siegmund, A., Suslow, T., Pedersen, A., Spitzberg, K., Kersting, A., Rothermundt, M., Arolt, V., Heindel, W., and Pfleiderer, B., J. Psychiatr. Res., 2007, vol. 41, pp. 625–634.

    Article  PubMed  Google Scholar 

  3. Uzbekov, M.G., Misionzhnik, E.Yu., Shmukler, A.B., Gurovich, I.Ya., Gryzunov, Yu.A., Smolina, N.V., Kalinina, V.V., Sokolova, T.N., Moskvitina, T.A., and Shevchenko, V.A., Zhurn. Nevrol. i Psikhiatr. im. S.S. Korsakova, 2009, vol. 109, no. 5, pp. 48–52.

    CAS  Google Scholar 

  4. Uzbekov, M.G., Misionzhnik, E.Yu., Gurovich, I.Y., and Shmukler, A.B., Acta Neuropsychiatrica, 2013, vol. 25, no. 5, pp. P. 268–274.

    Article  PubMed  Google Scholar 

  5. Gysin, R., Kraftsik, R., Boulat, O., Bovet, P., Conus, P., Comte-Krieger, E., Polari, A., Steullet, P., Preisig, M., Teichmann, T., Cuenod, M., and Do, K.Q., Antioxid. Redox Signal, 2011, vol. 15, no. 7, pp. 2003–2010.

    Article  CAS  PubMed  Google Scholar 

  6. Dietrich-Muszalska, A., Olas, B., Glowacki, R., and Bald, E., Neuropsychobiology, 2009, vol. 59, no. 1, pp.1–7.

    Article  CAS  PubMed  Google Scholar 

  7. Mahadik, S.P. and Scheffer, R.E., Prostaglandins, Leukotrienes and Essential Fatty Acids, 1996, vol. 55, nos. 1–2, pp. 45–54.

    Article  CAS  Google Scholar 

  8. Uzbekov, M.G., Sotsial’naya i Klinicheskaya Psikhiatriya, 2005, vol. 15, no. 2, pp. 108–110.

    Google Scholar 

  9. Peters, T.J., All about Albumin: Biochemistry, Genetics and Medical Applications, San Diego: Academic Press, 1995.

    Google Scholar 

  10. Jocelyn, P.C., Biochemistry of the SH Group, London, New York: Academic Press, 1972.

    Google Scholar 

  11. Pikkering, U.F., Sovremennaya analiticheskaya khimiya (Modern Analytical Chemistry), Moscow: Khimiya, 1977.

    Google Scholar 

  12. Gryzunov, Y.A., Arroyo, A., Vigne, J.L., Zhao, Q., Tyurin, V.A., Hubel, C.A., Gandley, R.E., Vladimirov, Yu.A., Taylor, R.N., and Kagan, V.E., Arch. Biochem. Biophys., 2003, vol. 413, no. 1, pp. 53–66.

    Article  CAS  PubMed  Google Scholar 

  13. Vasileva, A., Jakob, M., and Hasko, F., J. Chromatogr., 1981, vol. 216, pp. 279–284.

    Article  CAS  PubMed  Google Scholar 

  14. Ellman, G.L., Arch. Biochem. Biophys., 1959, vol. 82, no. 1, pp. 70–77.

    Article  CAS  PubMed  Google Scholar 

  15. Guggenheim, E.A., Thermodynamics: An Advanced Treatment for Chemists and Physicists, Amsterdam: North-Holland Publishing Company, 1949.

    Google Scholar 

  16. Ivanova, S.A., Smirnova, L.P., Shchigoreva, Yu.G., Boiko, A.S., Semke, A.V., Uzbekov, M.G., and Bokhan, N.A., Neurochem. J., 2014, vol. 8, no. 1, pp. 66–70.

    Article  CAS  Google Scholar 

  17. Uzbekov, M.G., Neurochem. J., 2009, vol. 3, no. 4, pp. 305–308.

    Article  Google Scholar 

  18. Beckman, K.B. and Ames, B.N., Physiol. Rev., 1998, vol. 78, pp. 547–581.

    Article  CAS  PubMed  Google Scholar 

  19. Ravinder, R., Mahadik, S.P., Mukherjee, S., and Murthy, J.N., Biol. Psychiatry, 1991, vol. 30, pp. 409–412.

    Article  Google Scholar 

  20. Mahadik, S.P., Mukherjee, S., Correnti, E.E., and Scheffer, R.E., Schizophr. Res., 1995, vol. 15, p.66.

    Google Scholar 

  21. Mahadik, S.P. and Mukherjee, S., Schizophr. Res., 1996, vol. 19, pp. 1–17.

    Article  CAS  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to M. G. Uzbekov.

Additional information

Original Russian Text © V.V. Brilliantova, N.V. Smolina, T.I. Syreishchikova, M.G. Uzbekov, G.E. Dobretsov, 2018, published in Neirokhimiya, 2018, Vol. 35, No. 1, pp. 96–100.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Brilliantova, V.V., Smolina, N.V., Syreishchikova, T.I. et al. The State of Albumin Thiol Groups in Patients with the First Episode of Schizophrenia. Neurochem. J. 12, 107–110 (2018). https://doi.org/10.1134/S1819712418010038

Download citation

  • Received:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1134/S1819712418010038

Keywords

Navigation